IC-86621

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameIC-86621
Drug Alias NameIC-86621
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-dependent protein kinase inhibitors
TargetsDNA-dependent protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIcos Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIcos Corporation
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A